Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione |
---|---|
Date Designated: | 04/16/2018 |
Orphan Designation: | Treatment of inherited mitochondrial respiratory chain disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Abliva AB Medicon Village Lund Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-